Back to All Posts
POST

HBOT for Male Fertility: How Hyperbaric Oxygen Therapy Improves Sperm Quality

hbot-male-fertility-hyperbaric-oxygen-therapy-sperm-quality-los-angeles
July 11, 2026

TLDR

Male factor infertility contributes to roughly 50% of all infertility cases. Oxidative stress and poor testicular oxygenation are among the leading biological causes. Hyperbaric oxygen therapy (HBOT) addresses both mechanisms directly — flooding reproductive tissues with high-concentration oxygen, neutralizing reactive oxygen species, and triggering the antioxidant enzymes that protect sperm DNA. A 2025 systematic review and meta-analysis of nine randomized controlled trials (Liu et al., Medical Gas Research) confirmed that HBOT significantly improves sperm density, motility, viability, and morphology while increasing clinical pregnancy rates. At OxygenWell in Sherman Oaks and Calabasas, CA, Dr. Beth Meneley's team offers a dedicated 20–30 session male fertility protocol — no hormones, no injections, no drugs.

Table of Contents

How Common Is Male Factor Infertility?

Infertility affects approximately 186 million people worldwide, and the male partner is the contributing factor in roughly half of all cases — either as the sole cause or as a contributing factor alongside female factors. A study tracking U.S. infertility rates found that 11–13% of men face fertility challenges during their reproductive years.

Despite these numbers, male infertility historically receives far less clinical attention than female infertility. Common diagnostic findings include:

  • Oligospermia — low sperm count
  • Asthenozoospermia — poor sperm motility
  • Teratozoospermia — abnormal sperm morphology
  • Elevated sperm DNA fragmentation — structural damage to sperm genetic material
  • Idiopathic infertility — no clearly identified cause on standard testing

Many of these conditions share a common upstream driver: oxidative stress in the male reproductive tract.

Why Oxidative Stress Is the Root Cause You May Be Missing

Sperm cells are among the most oxidatively vulnerable cells in the human body. Their plasma membranes are rich in polyunsaturated fatty acids — the same quality that gives sperm the membrane fluidity needed for motility also makes them highly susceptible to attack by reactive oxygen species (ROS).

When ROS levels overwhelm the body's antioxidant defenses, a cascade of damage follows:

  • Lipid peroxidation destroys sperm membrane integrity, reducing motility and the ability to fuse with an egg
  • DNA fragmentation damages the genetic payload the sperm carries, increasing miscarriage risk and reducing IVF success rates even when fertilization occurs
  • Protein oxidation impairs the mitochondrial function that powers sperm movement

A 2025 review in Frontiers in Endocrinology confirmed that oxidative stress-induced sperm dysfunction — through lipid peroxidation, DNA fragmentation, and protein oxidation — is among the central mechanisms in male infertility (Wang & Fu, Frontiers in Endocrinology, 2025).

The testes are also highly oxygen-dependent. Spermatogenesis — the continuous production of new sperm — is an energy-intensive process requiring robust blood flow and oxygen delivery. Conditions that impair testicular microcirculation (varicocele, metabolic dysfunction, chronic inflammation) reduce local oxygen tension and create exactly the hypoxic environment where ROS production accelerates and sperm quality declines.

This is where HBOT intervenes at the root cause level.

How HBOT Improves Sperm Quality: The Biological Mechanism

Hyperbaric oxygen therapy involves breathing 100% medical-grade oxygen inside a pressurized chamber at 1.5–2.0 atmospheres absolute (ATA). At this pressure, oxygen dissolves directly into plasma, cerebrospinal fluid, and lymphatic fluid — bypassing the hemoglobin-bound oxygen pathway and saturating tissues that normally receive limited oxygen delivery.

In the context of male reproductive health, this creates several measurable effects:

1. Restoration of Testicular Oxygen Tension

HBOT delivers oxygen concentrations 10–15 times above atmospheric levels to tissues throughout the body, including the testes and epididymis. This reverses the hypoxic microenvironment that impairs spermatogenesis and drives ROS overproduction.

2. Reduction of Oxidative Stress

Repeated HBOT sessions upregulate the body's endogenous antioxidant enzyme systems — superoxide dismutase (SOD) and glutathione in particular. SOD is the primary enzymatic defense against superoxide radicals in sperm. Research tracking biomarkers across HBOT protocols documents SOD rising from approximately 980 U/mL at baseline to 1,980 U/mL after 40–60 sessions, and glutathione climbing from 6.2 µM to 12.6 µM — a near-doubling of the body's core antioxidant capacity. This systemic antioxidant upregulation directly reduces the ROS burden on developing sperm cells.

3. Reduced Seminal Fructose Levels

HBOT reduces fructose concentrations in semen. Elevated seminal fructose is associated with sperm dysfunction; its reduction correlates with improved overall sperm function and motility.

4. Angiogenesis and Improved Microcirculation

HBOT stimulates VEGF (vascular endothelial growth factor), which promotes new capillary growth. In the testes and epididymis, improved microcirculation means more consistent oxygen and nutrient delivery throughout the 74-day spermatogenesis cycle.

5. Mitochondrial Optimization

Sperm motility depends entirely on mitochondrial ATP production in the sperm midpiece. HBOT's enhancement of mitochondrial function — documented in longevity research through improved ATP synthesis and reduced mitochondrial oxidative damage — translates directly into improved forward sperm motility.

Which Sperm Parameters Does HBOT Improve?

The 2025 systematic review and meta-analysis by Liu et al., published in Medical Gas Research, analyzed nine randomized controlled trials evaluating HBOT for male infertility. The findings were consistent and significant across all major sperm parameters (Liu et al., Medical Gas Research, 2025):

  • Sperm density (count): Significantly increased sperm concentration
  • Sperm motility: Significantly improved forward sperm movement
  • Sperm viability (survival): Significantly enhanced percentage of living sperm
  • Sperm morphology: Improved proportion of normally shaped sperm
  • Normal sperm rate: Increased across treatment groups
  • Clinical pregnancy rate: Higher in HBOT-treated groups vs. controls

The researchers concluded: "HBOT, when used in conjunction with other treatments, significantly improves sperm density, motility, and viability and reduces abnormalities, ultimately increasing male fertility. It is an effective adjunctive therapy for the treatment of male infertility."

Earlier clinical evidence from Yildiz et al. (2019) reported statistically significant improvements in sperm motility and morphology following HBOT, while Shen et al. (2016) documented improvements across semen parameters alongside increased pregnancy rates.

Can HBOT Reduce Sperm DNA Fragmentation?

Sperm DNA fragmentation (SDF) is one of the most clinically significant — and most overlooked — causes of male infertility. Standard semen analysis does not measure DNA integrity. A man can have a "normal" semen analysis and still have sperm DNA fragmentation rates high enough to prevent implantation, cause early miscarriage, or limit IVF success.

Oxidative stress is the primary driver of SDF. ROS attack sperm DNA directly, causing strand breaks that mature sperm cannot repair (unlike somatic cells, mature sperm have no DNA repair machinery).

Because HBOT targets oxidative stress through multiple pathways simultaneously — reducing ROS load, upregulating SOD and glutathione, improving mitochondrial efficiency — it addresses the upstream cause of DNA damage rather than managing downstream consequences. Biomarker data from HBOT protocols shows reductions in 8-OHdG (a marker of oxidative DNA damage) and MDA (malondialdehyde, a lipid peroxidation marker), both of which reflect the systemic oxidative burden on sperm.

For couples who have experienced recurrent implantation failure or early pregnancy loss where female factors have been excluded, elevated SDF in the male partner is a likely contributor — and HBOT represents a meaningful, non-invasive intervention to address it.

What Does the Clinical Research Show?

The clinical evidence base for HBOT and male fertility has grown substantially:

  • Liu et al., Medical Gas Research (2025): The most comprehensive analysis to date — a systematic review of nine RCTs confirming HBOT significantly improves all key sperm parameters and increases clinical pregnancy rates (PubMed)
  • Yildiz et al. (2019): Statistically significant improvements in sperm motility and morphology following HBOT
  • Shen et al. (2016): Improvements in semen parameters and pregnancy rates in HBOT-treated men
  • Ozgok Kangal et al., Turkish Journal of Urology (2020): HBOT added to assisted reproductive technology (ART) protocols for male infertility produced improved outcomes compared to ART alone (PMC)
  • Hyperbaric Oxygen Institute, Dr. Leigh Erin Connealy, MD (2023): Reviewed HBOT's role in improving sperm quality, motility, count, and addressing erectile dysfunction through enhanced circulation and reduced oxidative stress
  • Ongoing Clinical Trial NCT05842239: Currently evaluating HBOT specifically for men with infertility due to oligospermia — reflecting growing institutional interest in this application

The research consistently positions HBOT as a meaningful adjunctive therapy — and that framing is exactly how the OxygenWell team integrates it into each patient's broader fertility plan.

Can HBOT Be Combined With IVF or IUI?

Yes — and in many cases, this combination produces better outcomes than either approach alone. For couples undergoing IVF or IUI where male factor infertility is a contributing issue, improving baseline sperm quality before the retrieval cycle changes the biological starting point.

Because spermatogenesis takes approximately 74 days (roughly 10–11 weeks), the optimal window for an HBOT course targeting sperm quality is 8–12 weeks before a planned retrieval or insemination cycle. Beginning a 20–30 session HBOT protocol during this window gives sperm cells developing from spermatogonia to mature spermatozoa the benefit of an improved oxidative environment throughout their entire maturation cycle.

HBOT works particularly well alongside:

  • IUI preparation — improving sperm count, motility, and morphology before insemination
  • IVF cycles — reducing SDF rates and improving morphology prior to ICSI, where sperm selection is critical
  • Natural conception attempts — especially where standard semen analysis is "borderline normal" but DNA fragmentation testing reveals elevated damage

For couples where both male and female factors are present, OxygenWell's team can coordinate complementary HBOT protocols to support both partners simultaneously. Learn more about our HBOT for IVF and female fertility protocol.

How Many HBOT Sessions Are Needed?

For male fertility optimization, research protocols and clinical experience converge on:

  • Total sessions: 20–30
  • Frequency: Daily or near-daily (5 sessions per week)
  • Pressure: 1.5–2.0 ATA
  • Duration per session: 60–90 minutes
  • Ideal start time: 8–12 weeks before planned IVF retrieval or conception attempt

Some men — particularly those with more severe oligospermia, elevated SDF, or concurrent conditions — benefit from the upper range of 30 sessions. OxygenWell's intake evaluation and, where appropriate, biomarker testing (including sperm DNA fragmentation index, oxidative stress markers, and baseline semen analysis) inform the individualized protocol recommendation.

Semen analysis conducted 10–12 weeks after completing an HBOT course provides the most accurate picture of treatment response, as it captures the full new cohort of sperm produced under improved oxidative conditions.

Is HBOT Safe for Men With Fertility Concerns?

HBOT has an established safety record built across decades of clinical use and more than 50,000 supervised sessions at OxygenWell alone. For men pursuing fertility optimization, HBOT carries no systemic hormonal effects, no impact on the HPG axis, and no known reproductive toxicity risk.

  • No hormones, no injections, no drugs — HBOT works through physics and biology, not pharmaceutical intervention
  • No contraindications specific to fertility treatment — does not interfere with IVF medications in the male partner
  • Non-invasive — patients rest comfortably in the chamber breathing oxygen; no needles, no incisions, no recovery time
  • Well-tolerated — the most commonly reported sensation is mild ear pressure during pressurization, comparable to descending in an airplane

At OxygenWell, all sessions are supervised by Certified Hyperbaric Technicians (CHTs), most of whom are EMT-certified, with a PA on-site during most weekday hours. Each patient undergoes a thorough intake evaluation to confirm candidacy before beginning any protocol.

The OxygenWell Male Fertility Protocol

OxygenWell's male fertility protocol is designed around the biological reality that meaningful improvements in sperm parameters require time — enough time to support at least one complete spermatogenesis cycle under improved oxidative conditions.

Protocol Overview

  • Sessions: 20–30 total
  • Pressure: 1.5–2.0 ATA, 100% medical-grade oxygen
  • Duration: 60–90 minutes per session
  • Frequency: Daily or 5x/week
  • Optimal timing: Begin 8–12 weeks before planned retrieval or conception attempt

Biomarkers We Can Track

  • Baseline and post-protocol semen analysis (count, motility, morphology, volume)
  • Sperm DNA fragmentation index (DFI)
  • Oxidative stress biomarkers: 8-OHdG, MDA
  • Antioxidant status: SOD, glutathione
  • Inflammatory markers: CRP, IL-6

Complementary Therapies

OxygenWell also offers red light therapy (photobiomodulation). Near-infrared light at 810–880nm supports mitochondrial ATP synthesis at the cellular level. Since sperm motility is entirely ATP-dependent, the combination of HBOT and red light therapy creates a synergistic environment for sperm quality improvement.

Why OxygenWell Is Uniquely Positioned for Male Fertility

Most hyperbaric oxygen therapy centers in Los Angeles have no background in reproductive medicine. OxygenWell is different.

Dr. Beth Meneley, DAOM, L.Ac., brings over 20 years of specialization in fertility — both male and female — to her role as Wellness Director and Co-Owner of OxygenWell. She is the founder of the Tao of Venus Acupuncture Center and The Functional Fertility Method, an integrative framework combining functional medicine principles and Chinese medicine to support conception for both partners. She holds a Doctorate in Acupuncture and Oriental Medicine and has served as a Primary Healthcare Provider and Integrative Medicine Practitioner for 25+ years.

Dr. Meneley first encountered HBOT over two decades ago while exploring integrative approaches to cancer care. Her deep understanding of root-cause physiology — including oxidative stress, mitochondrial dysfunction, inflammation, and the interplay of these forces in reproductive health — informs how OxygenWell designs fertility protocols that go beyond a one-size-fits-all session count.

This combination of hyperbaric medicine expertise and deep fertility clinical background makes OxygenWell uniquely suited to evaluate male fertility cases, design appropriate protocols, and coordinate care with reproductive endocrinologists and fertility specialists across Los Angeles.

OxygenWell is rated to 2.4 ATA with 100% medical-grade oxygen through a high-flow system — not a standard oxygen concentrator. Sessions are conducted in grounded monoplace chambers meeting the highest safety standards. This level of equipment and oversight is rare among HBOT centers in Southern California.

Learn more about what sets OxygenWell apart from other hyperbaric centers in Los Angeles.

Take the Next Step: Free Discovery Call

If you or your partner are facing male factor infertility — or if IVF cycles have fallen short and the male factor has not been fully addressed — HBOT may be the missing piece.

OxygenWell offers a free discovery call to discuss your situation, review your current testing, and determine whether a male fertility HBOT protocol is right for you. Our team at Sherman Oaks and Calabasas is available six days a week with extended hours including evenings — designed for working patients who cannot sacrifice their schedule for treatment.

No hormones. No injections. No drugs.
Just oxygen, pressure, and the body's own biology — optimized.

OxygenWell Hyperbaric & Regenerative Medicine Center
Sherman Oaks & Calabasas, CA
(818) 661-0939
www.oxygenwell.com

Schedule your free discovery call today →

Clinical References

  • Liu et al. "Hyperbaric oxygen therapy for male infertility: a systematic review and meta-analysis on improving sperm quality and fertility outcomes." Medical Gas Research, 2025. PubMed
  • Wang Y, Fu X. "Mechanisms of oxidative stress-induced sperm dysfunction." Frontiers in Endocrinology, 2025. Frontiers
  • Ozgok Kangal K, et al. "Assisted reproductive treatments with hyperbaric oxygen therapy in male infertility." Turkish Journal of Urology, 2020. PMC
  • Yildiz S, et al. "Hyperbaric oxygen therapy and sperm motility and morphology." 2019.
  • Shen et al. "HBOT for semen parameters and pregnancy rates." 2016.
  • Hyperbaric Oxygen Institute, Dr. Leigh Erin Connealy, MD. 2023. Source
Related Post
Refer a Patient — Hyperbaric Oxygen Therapy Los Angeles
Refer a Patient — Hyperbaric Oxygen Therapy Los Angeles
July 11, 2026